SMS Pharmaceuticals Limited (BOM:532815)
234.60
+2.65 (1.14%)
At close: Aug 14, 2025
SMS Pharmaceuticals Revenue
SMS Pharmaceuticals had revenue of 1.96B INR in the quarter ending June 30, 2025, with 19.21% growth. This brings the company's revenue in the last twelve months to 8.14B, up 10.29% year-over-year. In the fiscal year ending March 31, 2025, SMS Pharmaceuticals had annual revenue of 7.83B with 10.36% growth.
Revenue (ttm)
8.14B
Revenue Growth
+10.29%
P/S Ratio
2.58
Revenue / Employee
6.80M
Employees
1,197
Market Cap
21.04B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 7.83B | 734.85M | 10.36% |
Mar 31, 2024 | 7.09B | 1.87B | 35.86% |
Mar 31, 2023 | 5.22B | 21.77M | 0.42% |
Mar 31, 2022 | 5.20B | -433.03M | -7.69% |
Mar 31, 2021 | 5.63B | 1.49B | 35.93% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,839.41B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,503.84B |
Hindustan Unilever | 639.28B |
Infosys | 1,672.76B |
SMS Pharmaceuticals News
- 13 days ago - SMS Pharmaceuticals Q1 Results: Revenue jumps 19% YoY to Rs 196.05 crore, Net profit up14% YoY - Business Upturn
- 2 months ago - SMS Pharmaceuticals share jump 6% after its Hyderabad facility clears USFDA inspection with zero observations - Business Upturn
- 2 months ago - SMS Pharmaceuticals clears second USFDA inspection at Hyderabad lab with zero observations - Business Upturn
- 4 months ago - SMS Pharmaceuticals’ Visakhapatnam facility receives WHO prequalification - Business Upturn